Oncolytics Biotech issued new U.S. patent (News-Medical-Net)
Oncolytics Biotech issued new U.S. patent (News-Medical-Net)
Oncolytics Biotech Inc. has announced that it has been granted its 31st U.S. Patent, # 7,476,382, entitled “Reovirus for the Treatment of Neoplasia.” The patent includes claims to pharmaceutical compositions containing reovirus.